Showing results (151-160 of 250) with videos related to
Sort By:
Pageof 25
Journal of Neuro-Oncology|October 14, 2008
A North American brain tumor consortium phase II study of poly-ICLC for adult patients with recurrent anaplastic gliomasNicholas Butowski, Kathleen R Lamborn, Bee L Lee, et al.Neurology|May 6, 2018
New diagnosis of cancer and the risk of subsequent cerebrovascular eventsBabak B Navi, George Howard, Virginia J Howard, et al.Neuro-Oncology|March 12, 2015
Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)Andrew B Lassman, Stephanie L Pugh, Mark R Gilbert, et al.Targeted Oncology|January 25, 2013
Cytokines associated with toxicity in the treatment of recurrent glioblastoma with afliberceptNicole Shonka, Yuji Piao, Mark Gilbert, et al.Journal of Thrombosis and Haemostasis : JTH|June 2, 2022
Ischemic stroke with cancer: Hematologic and embolic biomarkers and clinical outcomesBabak B Navi, Cenai Zhang, Carla P Sherman, et al.Cancer|August 27, 2015
Multicenter phase 2 study of patupilone for recurrent or progressive brain metastases from non-small cell lung cancerLakshmi Nayak, Lisa M DeAngelis, H Ian Robins, et al.Cell Stem Cell|December 11, 2012
MEF promotes stemness in the pathogenesis of gliomasElena Bazzoli, Teodoro Pulvirenti, Moritz C Oberstadt, et al.Medical Education Online|January 21, 2011
Standardized patient outcomes trial (SPOT) in neurologyJoseph E Safdieh, Andrew L Lin, Juliet Aizer, et al.Pituitary|July 10, 2023
The treatment of aggressive prolactinomas with everolimusAndrew L Lin, Eliza B Geer, Nupur Lala, et al.Journal of Neuro-Oncology|June 8, 2020
Cerebrospinal fluid circulating tumor cells as a quantifiable measurement of leptomeningeal metastases in patients with HER2 positive cancerRachna Malani, Martin Fleisher, Priya Kumthekar, et al.Pageof 25